Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000254181 | SCV000301786 | benign | not specified | 2016-01-28 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000343690 | SCV000481384 | benign | X-linked agammaglobulinemia with growth hormone deficiency | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. |
Illumina Laboratory Services, |
RCV000407074 | SCV000481385 | benign | X-linked agammaglobulinemia | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to rule this variant out of causing disease. Therefore, this variant is classified as benign. |
Gene |
RCV000254181 | SCV000512429 | benign | not specified | 2015-11-11 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Laboratory for Molecular Medicine, |
RCV000254181 | SCV000538509 | benign | not specified | 2016-03-28 | criteria provided, single submitter | clinical testing | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency |
Invitae | RCV000343690 | SCV001721002 | benign | X-linked agammaglobulinemia with growth hormone deficiency | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000407074 | SCV001775121 | benign | X-linked agammaglobulinemia | 2021-07-14 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000343690 | SCV001775122 | benign | X-linked agammaglobulinemia with growth hormone deficiency | 2021-07-14 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV003114414 | SCV003799705 | benign | not provided | 2023-11-29 | criteria provided, single submitter | clinical testing | |
Unidad de Genómica Garrahan, |
RCV000254181 | SCV004233340 | benign | not specified | 2024-01-24 | criteria provided, single submitter | clinical testing | This variant is classified as Benign based on local population frequency. This variant was detected in 53% of patients studied by a panel of primary immunodeficiencies. Number of patients: 50. Only high quality variants are reported. |